Allgemeine Gynäkologie/Rheumatologie. Rheumatische Erkrankungen in der Schwangerschaft

Entzündlich-rheumatische Erkrankungen betreffen gehäuft das weibliche Geschlecht, und nicht selten erkranken Frauen vor Abschluss ihrer Familienplanung. Die Konsequenz ist, dass diese Patientinnen oft weniger Kinder als Frauen der Normalbevölkerung bekommen. Gründe dafür sind teils persönliche Entscheidungen angesichts der Sorge um die eigene Gesundheit bzw. die des Kindes [1]. So kann eine Schwangerschaft Auswirkungen auf den Verlauf der rheumatischen Erkrankung und die Prognose nehmen – andererseits sind erhöhte Raten an Schwangerschaftsverlusten und -komplikationen bekannt. Ein sensibles Thema ist auch die medikamentöse Therapie, die vielfach benötigt wird, um die Erkrankung in Remission zu halten. Im Hinblick auf mögliche fetale Risiken ist sie aber anzupassen.

• Literatur

• 1 Clowse ME, Chakravarty E, Costenbader KH et al. Effects of infertility, pregnancy loss, and patient concerns on family size of women with rheumatoid arthritis and systemic lupus erythematosus. Arthritis Care Res (Hoboken) 2012; 64: 668-674
• 2 Jawaheer D, Zhu JL, Nohr EA et al. Time to pregnancy among women with rheumatoid arthritis. Arthritis Rheum 2011; 63: 1517-1521
• 3 Hazes J, Coulie PG, Geenen V et al. Rheumatoid arthritis and pregnancy: evolution of disease activity and pathophysiological considerations for drug use. Rheumatology (Oxford) 2011; 50: 1955-1968
• 4 de Man YA, Dolhain RJ, van de Geijn FE et al. Disease activity of rheumatoid arthritis during pregnancy: results from a nationwide prospective study. Arthritis Rheum 2008; 59: 1241-1248
• 5 Lin HC, Chen SF, Lin HC et al. Increased risk of adverse pregnancy outcomes in women with rheumatoid arthritis: a nationwide population-based study. Ann Rheum Dis 2010; 96: 715-717
• 6 de Man YA, Hazes JM, van der Heide H et al. Association of higher rheumatoid arthritis disease activity during pregnancy with lower birth weight: results of a national prospective study. Arthritis Rheum 2009; 60: 3196-3206
• 7 Norgaard M, Larsson H, Pedersen L et al. Rheumatoid arthritis and birth outcomes: a Danish and Swedish nationwide prevalence study. J Intern Med 2010; 268: 329-337
• 8 Wallenius M, Skomsvoll JF, Irgens LM et al. Pregnancy and delivery in women with chronic inflammatory arthritides with a specific focus on first birth. Arthritis Rheum 2011; 63: 1534-1542
• 9 Clowse ME. Lupus activity in pregnancy. Rheum Dis Clin North Am 2007; 33: 237-252
• 10 Lateef A, Petri M. Managing lupus patients during pregnancy. Best Pract Res Clin Rheumatol 2013; 27: 435-447
• 11 Clowse ME, Magder L, Witter F et al. Hydroxychloroquine in lupus pregnancy. Arthritis Rheum 2006; 54: 3640-3647
• 12 Clark CA, Spitzer KA, Laskin CA. Decrease in pregnancy loss rates in patients with systemic lupus erythematosus over a 40-year period. J Rheumatol 2005; 32: 1709-1712
• 13 Clowse ME, Magder LS, Witter F et al. The impact of increased lupus activity on obstetric outcomes. Arthritis Rheum 2005; 52: 514-521
• 14 Chakravarty EF, Colón I, Langen ES et al. Factors that predict prematurity and preeclampsia in pregnancies that are complicated by systemic lupus erythematosus. Am J Obstet Gynecol 2005; 192: 1897-1904
• 15 Clowse ME, Jamison M, Myers E et al. A national study of the complications of lupus in pregnancy. Am J Obstet Gynecol 2008; 199: 127.e1-127.e6
• 16 Chakravarty EF, Nelson L, Krishnan E. Obstetric hospitalizations in the United States for women with systemic lupus erythematosus and rheumatoid arthritis. Arthritis Rheum 2006; 54: 899-907
• 17 Smyth A, Oliveira GH, Lahr BD et al. A systematic review and meta-analysis of pregnancy outcomes in patients with systemic lupus erythematosus and lupus nephritis. Clin J Am Soc Nephrol 2010; 5: 2060-2068
• 18 Bertsias GK, Tektonidou M, Amoura Z et al. Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis. Ann Rheum Dis 2012; 71: 1771-1782
• 19 Roberge S, Villa P, Nicolaides K et al. Early administration of low-dose aspirin for the prevention of preterm and term preeclampsia: a systematic review and meta-analysis. Fetal Diagn Ther 2012; 31: 141-146
• 20 Shand AW, Algert CS, March L et al. Second pregnancy outcomes for women with systemic lupus erythematosus. Ann Rheum Dis 2013; 72: 547-551
• 21 Ruiz-Irastorza G, Crowther M, Branch W et al. Antiphospholipid syndrome. Lancet 2010; 376: 1498-1509
• 22 Ruffatti A, Tonello M, Visentin MS et al. Risk factors for pregnancy failure in patients with anti-phospholipid syndrome treated with conventional therapies: a multicentre, case-control study. Rheumatology (Oxford) 2011; 50: 1684-1689
• 23 Bramham K, Hunt BJ, Germain S et al. Pregnancy outcome in different clinical phenotypes of antiphospholipid syndrome. Lupus 2010; 19: 58-64
• 24 Danza A, Ruiz-Irastorza G, Khamashta M. Antiphospholipid syndrome in obstetrics. Best Pract Res Clin Obstet Gynaecol 2012; 26: 65-76
• 25 Izmirly PM, Rivera TL, Buyon JP. Neonatal lupus syndromes. Rheum Dis Clin North Am 2007; 33: 267-285
• 26 Izmirly PM, Saxena A, Kim MY et al. Maternal and fetal factors associated with mortality and morbidity in a multi-racial/ethnic registry of anti-SSA/Ro-associated cardiac neonatal lupus. Circulation 2011; 124: 1927-1935
• 27 Izmirly PM, Kim MY, Llanos C et al. Evaluation of the risk of anti-SSA/Ro-SSB/La antibody-associated cardiac manifestations of neonatal lupus in fetuses of mothers with systemic lupus erythematosus exposed to hydroxychloroquine. Ann Rheum Dis 2010; 69: 1827-1830
• 28 Oestensen M, Förger F. Management of RA medications in pregnant patients. Nat Rev Rheumatol 2009; 5: 382-390
• 29 Fischer-Betz R, Späthling-Mestekemper S. [Pregnancy and inflammatory rheumatic diseases]. Z Rheumatol 2013; 72: 669-682
• 30 Fischer-Betz RE, Schneider M. [Biologics during pregnancy and breast-feeding]. Z Rheumatol 2010; 69: 780-787